LEADER 01744oam  2200421   450 
001 9910583308303321
005 20190911100031.0
010   $a0-12-801903-4
010   $a0-12-801893-3
035   $a(OCoLC)1004738996
035   $a(MiFhGG)GVRL7ZIO
035   $a(EXLCZ)994100000000459855
100   $a20180430h20172017  uy             0
101 0 $aeng
135   $aurun|---uuuua
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 00$aHuntington disease /$fvolume editors, Andrew S. Feigin and Karen E. Anderson
210  1$aAmsterdam :$cElsevier,$d[2017]
210  4$d?2017
215   $a1 online resource (xvi, 297 pages) $cillustrations (some color)
225 1 $aHandbook of Clinical Neurology ;$vVolume 44
320   $aIncludes bibliographical references at the end of each chapters and index.
327   $aSection 1. Basic science -- Section 2. Clinical aspects -- Section 3. Treatment of Huntington disease -- Section 4. Experimental therapeutics -- Section 5. Biomarkers.
330   $aThis book summarizes the most recent findings related to Huntington Disease, providing coverage for clinical/research specialists looking to expand their knowledge, as well as groundwork on the disease for advanced students from various backgrounds, including neurology, psychiatry, neuropsychology, and genetics.
410  0$aHandbook of clinical neurology ;$vv. 144.
606   $aHuntington's disease
615  0$aHuntington's disease.
676   $a616.851
702   $aFeigin$b Andrew S.
702   $aAnderson$b Karen E.$cM.D.,
801  0$bMiFhGG
801  1$bMiFhGG
906   $aBOOK
912   $a9910583308303321
996   $aHuntington disease$92211704
997   $aUNINA